SCHEMBL7748802

SCHEMBL7748802

Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 2/20 0.41
ALDH1A1 P00352 6/20 0.39
TSHR P16473 3/20 0.38
HPGD P15428 2/20 0.38
CYP3A4 P08684 1/20 0.38
ALOX15 P16050 1/20 0.38
HIF1A Q16665 1/20 0.38
TXNRD1 Q16881 1/20 0.38
TXNRD3 Q86VQ6 1/20 0.38
TXNRD2 Q9NNW7 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KDM4E B2RXH2 3/20 0.36
PKM P14618 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 2/20 0.34
POLB P06746 2/20 0.34
GLA P06280 1/20 0.34
MAPK1 P28482 1/20 0.34
CES2 O00748 1/20 0.34
GPR35 Q9HC97 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3131496 0.86 PTPN5 (0.47) PTPN5ALDH1A1TSHRHPGDCYP3A4
SCHEMBL1042850 0.84 ALDH1A1 (0.45) ALDH1A1TSHRHPGDCYP3A4ALOX15
SCHEMBL1040870 0.80 TSHR (0.45) ALDH1A1TSHRCYP3A4ALOX15KDM4E
SCHEMBL10776564 0.80 CYP3A4 (0.41) ALDH1A1TSHRHPGDCYP3A4ALOX15
SCHEMBL1769094 0.80 PTPN5 (0.42) PTPN5ALDH1A1TSHRHPGDCYP3A4
SCHEMBL31304780 0.80 PTPN5 (0.42) PTPN5ALDH1A1TSHRHPGDCYP3A4
SCHEMBL9610071 0.78 RAPGEF4 (0.42) PTPN5ALDH1A1TSHRHPGDCYP3A4
SCHEMBL9560970 0.78 EPAS1 (0.37) TSHRGAAPOLBGLACA12
SCHEMBL330815 0.78 ALDH1A1 (0.43) PTPN5ALDH1A1TSHRHPGDKDM4E
SCHEMBL11055186 0.78 PTPN5 (0.41) PTPN5ALDH1A1TSHRHPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0912502-B1 2-CHLORO-3,5-BIS(TRIFLUOROMETHYL)PHENYL BENZOYL UREA DERIVATIVE AND PROCESS FOR PREPARING THE SAME DONGBU HANNONG CHEMICAL CO LTD (KR) 2001-01-17 EP claimed
US-6022882-A POTENT GROWTH-RETARDING ACTIVITY AGAINST PESTS DONGBU HANNONG CHEMICAL CO., LTD. (KR) 2000-02-08 US claimed
EP-0912502-A1 2-CHLORO-3,5-BIS(TRIFLUOROMETHYL)PHENYL BENZOYL UREA DERIVATIVE AND PROCESS FOR PREPARING THE SAME Hanwha Corporation (KR) 1999-05-06 EP claimed
WO-1998000394-A1 2-CHLORO-3,5-BIS(TRIFLUOROMETHYL)PHENYL BENZOYL UREA DERIVATIVE AND PROCESS FOR PREPARING THE SAME HANWHA CORPORATION (KR) 1998-01-08 WO claimed
US-12054484-B2 Substituted tetrahydropyrans as CCR2 modulators CHEMOCENTRYX, INC. (US) 2024-08-06 US disclosed
US-11713293-B2 Substituted biaryl sulfonamides and the use thereof NOVOMEDIX, LLC (US) 2023-08-01 US disclosed
US-20230180754-A1 HETEROCYCLIC COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS BASF SE (DE) 2023-06-15 US disclosed
CN-109574956-B Thiadiazole amide compound and application thereof 沈阳中化农药化工研发有限公司 2023-04-07 CN disclosed
EP-4149936-A1 HETEROCYCLIC COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS BASF SE (DE) 2023-03-22 EP disclosed
CN-115551848-A Heterocyclic compounds for controlling invertebrate pests 巴斯夫欧洲公司 2022-12-30 CN disclosed
US-20220153733-A1 SUBSTITUTED TETRAHYDROPYRANS AS CCR2 MODULATORS CHEMOCENTRYX, INC. 2022-05-19 US disclosed
US-20220153733-A1 SUBSTITUTED TETRAHYDROPYRANS AS CCR2 MODULATORS CHEMOCENTRYX, INC. 2022-05-19 US disclosed
EP-2925718-A1 SUBSTITUTED BIARYL SULFONAMIDES AND THE USE THEREOF Novomedix, LLC (US) 2015-10-07 EP disclosed
US-20140221411-A1 2-HYDROXYARYLAMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING SAME AS ACTIVE INGREDIENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2014-08-07 US disclosed
US-20140155477-A1 SUBSTITUTED BIARYL SULFONAMIDES AND THE USE THEREOF NOVOMEDIX, LLC (US) 2014-06-05 US disclosed
WO-2014085633-A1 SUBSTITUTED BIARYL SULFONAMIDES AND THE USE THEREOF NOVOMEDIX, LLC (US) 2014-06-05 WO disclosed
EP-0912502-B1 2-CHLORO-3,5-BIS(TRIFLUOROMETHYL)PHENYL BENZOYL UREA DERIVATIVE AND PROCESS FOR PREPARING THE SAME DONGBU HANNONG CHEMICAL CO LTD (KR) 2001-01-17 EP disclosed
US-6022882-A POTENT GROWTH-RETARDING ACTIVITY AGAINST PESTS DONGBU HANNONG CHEMICAL CO., LTD. (KR) 2000-02-08 US disclosed
EP-0912502-A1 2-CHLORO-3,5-BIS(TRIFLUOROMETHYL)PHENYL BENZOYL UREA DERIVATIVE AND PROCESS FOR PREPARING THE SAME Hanwha Corporation (KR) 1999-05-06 EP disclosed
WO-1998000394-A1 2-CHLORO-3,5-BIS(TRIFLUOROMETHYL)PHENYL BENZOYL UREA DERIVATIVE AND PROCESS FOR PREPARING THE SAME HANWHA CORPORATION (KR) 1998-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713293-B2 Substituted biaryl sulfonamides and the use thereof EIF2AK2, TP53, KRAS PTPN5 3286/4885ALDH1A1 2107/4885TSHR 3529/4885
US-20230180754-A1 HETEROCYCLIC COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS DDT, ACHE, CYCS PTPN5 1914/4885ALDH1A1 1384/4885TSHR 3767/4885
US-12054484-B2 Substituted tetrahydropyrans as CCR2 modulators CCR2, CCR1, CCR5 PTPN5 868/4885ALDH1A1 538/4885TSHR 1129/4885
US-20140155477-A1 SUBSTITUTED BIARYL SULFONAMIDES AND THE USE THEREOF EIF2AK2, TP53, KRAS PTPN5 3286/4885ALDH1A1 2107/4885TSHR 3529/4885
US-20140221411-A1 2-HYDROXYARYLAMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING SAME AS ACTIVE INGREDIENT TMPRSS2, TMPRSS4, PRSS2 PTPN5 995/4885ALDH1A1 740/4885TSHR 3299/4885
US-20220153733-A1 SUBSTITUTED TETRAHYDROPYRANS AS CCR2 MODULATORS CCR2, CCR1, CCR5 PTPN5 823/4885ALDH1A1 520/4885TSHR 1064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.